# ESiOR Oy (Finland)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/esior-oy-finland/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 21 |
| Citations | 2,292 |
| City | Kuopio |
| Country | FI |
| Description | ESiOR Oy (Finland) is a research organisation in Kuopio, FI. OpenAlex records 137 works and 2,292 citations for it. |
| Homepage | http://www.esior.fi/index.php/fi/ |
| OpenAlex ID | https://openalex.org/I4210124525 |
| ROR ID | https://ror.org/02eeq5d55 |
| Type | company |
| Works | 137 |

## University papers

- [A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents](https://scholariq.org/papers/a-systematic-review-and-economic-model-of-the-effectiveness-and-cost/)
- [The Functional Response of a Generalist Predator](https://scholariq.org/papers/the-functional-response-of-a-generalist-predator/)
- [Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation](https://scholariq.org/papers/etanercept-and-infliximab-for-the-treatment-of-psoriatic-arthritis-a-systematic/)
- [Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses](https://scholariq.org/papers/prenatal-screening-and-treatment-strategies-to-prevent-group-b-streptococcal-and/)
- [Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge](https://scholariq.org/papers/computer-modeling-of-diabetes-and-its-transparency-a-report-on-the-eighth-mount/)
- [Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses](https://scholariq.org/papers/preventive-strategies-for-group-b-streptococcal-and-other-bacterial-infections/)
- [The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis](https://scholariq.org/papers/the-cost-effectiveness-of-etanercept-and-infliximab-for-the-treatment-of/)
- [Effectiveness and Cost-Effectiveness of Antidepressants in Primary Care: A Multiple Treatment Comparison Meta-Analysis and Cost-Effectiveness Model](https://scholariq.org/papers/effectiveness-and-cost-effectiveness-of-antidepressants-in-primary-care-a/)
- [Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial](https://scholariq.org/papers/short-course-adjuvant-trastuzumab-therapy-in-early-stage-breast-cancer-in/)
- [Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis](https://scholariq.org/papers/is-primary-angioplasty-cost-effective-in-the-uk-results-of-a-comprehensive/)
- [Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data](https://scholariq.org/papers/development-and-internal-validation-of-a-discrete-event-simulation-model-of/)

## University researchers

- [Christian Asseburg](https://scholariq.org/researchers/christian-asseburg/)

## University top topics

Showing 8 of 25.

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Ophthalmology and Visual Impairment Studies](https://scholariq.org/topics/ophthalmology-and-visual-impairment-studies/)
- [Chronic Disease Management Strategies](https://scholariq.org/topics/chronic-disease-management-strategies/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.